共 172 条
[1]
Andrews HJ(2006)Prevention and treatment of venous thromboembolism Int Angiol 25 101-161
[2]
Arden GP(1981)Deep infection after total hip replacement J Bone Joint Surg Br 63-B 53-57
[3]
Hart GM(2006)Venous thromboembolism following major orthopedic surgery: what is the risk after discharge? Orthopedics 29 506-516
[4]
Owen JW(2012)Early surgical site infection in adult appendicular skeleton trauma surgery: a multicenter prospective series Orthop Traumatol Surg Res 98 684-689
[5]
Arcelus JI(2010)Surgical site infections in primary total hip and knee replacement surgeries, hemiarthroplasties, and osteosyntheses at a Brazilian university hospital Am J Infect Control 38 246-248
[6]
Kudrna JC(2008)Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty N Engl J Med 358 2765-2775
[7]
Caprini JA(2004)Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I J Thromb Haemost 2 1573-1580
[8]
Bonnevialle P(2005)A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial J Thromb Haemost 3 103-111
[9]
Bonnomet F(2011)Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial Thromb Haemost 105 721-729
[10]
Philippe R(2007)Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial Lancet 370 949-956